|
Characteristic
|
n = 22 COPD
|
|---|
|
Gender, male/female
|
9/13
|
|
Age, years
|
64 (9)
|
|
Current/ex-smokers
|
9/13
|
|
Pack years
|
46 (25)
|
|
Prescribed duala/tripleb inhaler therapy (n/n)
|
2/20
|
|
Prescribed supplemental oxygen (n)
|
0
|
|
Exacerbation history (n, zero/one/two exacerbation(s) in the last year)
|
13/8/1
|
|
CAT score
|
19.6 (8.4)
|
|
mMRC Dyspnoea Scale (n, grade 0/1/2/3/4)
|
3/10/4/4/1
|
|
FEV1 reversibility (%)
|
19 (13)
|
|
FEV1 (L)c
|
1.27 (0.34)
|
|
FEV1 (%)c
|
49 (9)
|
|
FVC (%)c
|
90 (10)
|
|
FEV1/FVC ratio (%)c
|
43 (11)
|
|
FEF25–75% (%)c
|
18 (7)
|
|
sGaw (L/s/kPa/L)
|
0.469 (0.195)
|
|
Raw (kPa/L/s)
|
0.512 (0.140)
|
|
RV (L)
|
3.16 (0.91)
|
|
RV (% predicted)
|
152 (35)
|
|
IC (% predicted)
|
80 (15)
|
|
FRC (% predicted)
|
139 (27)
|
|
TLC (% predicted)
|
114 (13)
|
|
R5 (kPa/L/s)c
|
0.570 (0.172)
|
|
R20 (kPa/L/s)c
|
0.395 (0.103)
|
|
R5–R20 (kPa/L/s)c
|
0.176 (0.118)
|
|
X5 (kPa/L/s)c
|
− 0.289 (0.150)
|
|
∆X5 (kPa/L/s)c
|
0.215 (0.194)
|
|
Fres (1/s)c
|
23.40 (5.07)
|
|
AX (kPa/L)c
|
2.427 (1.739)
|
- Data is mean (SD) where appropriate
- aICS/LABA
- bICS/LABA/LAMA
- cPost-bronchodilator
